Evidence map›Paper›PMID 37370838›Full record

ArticleCancers2023

The

Katrin Merk-Ahmad, Julia Bein, Sonja Scharf, Hendrik Schäfer, Tobias Bexte, Evelyn Ullrich, Andreas G Loth, Nadine Flinner, Tina Senff, Olga Schneider and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Katrin Merk-AhmadDr. Senckenberg Institute of Pathology, Goethe University, 60590 Frankfurt am Main, Germany.
Julia BeinDr. Senckenberg Institute of Pathology, Goethe University, 60590 Frankfurt am Main, Germany.
Sonja ScharfFrankfurt Institute for Advanced Studies, 60438 Frankfurt am Main, Germany.ORCID 0000-0002-0300-7027
Hendrik SchäferFrankfurt Institute for Advanced Studies, 60438 Frankfurt am Main, Germany.ORCID 0000-0002-5859-250X
Tobias BexteDepartment for Pediatrics, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.
Evelyn UllrichDepartment for Pediatrics, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0000-0001-8530-1192
Andreas G LothDepartment of Otolaryngology, Head and Neck Surgery, University Hospital Frankfurt, 60590 Frankfurt am Main, Germany.
Nadine FlinnerDr. Senckenberg Institute of Pathology, Goethe University, 60590 Frankfurt am Main, Germany.
Tina SenffInstitute of Pathology and Molecular Pathology, Helios Klinikum Wuppertal, 42283 Wuppertal, Germany.ORCID 0000-0003-1578-8163
Olga SchneiderDr. Senckenberg Institute of Pathology, Goethe University, 60590 Frankfurt am Main, Germany.
Martin-Leo HansmannFrankfurt Institute for Advanced Studies, 60438 Frankfurt am Main, Germany.
Matthieu PielInstitut Curie and Institut Pierre Gilles de Gennes, CNRS, UMR 144, PSL Research University, 75005 Paris, France.
Björn HäuplDepartment of Internal Medicine 2, Goethe University Hospital, 60590 Frankfurt am Main, Germany.
Thomas OellerichFrankfurt Cancer Institute, Goethe University, 60590 Frankfurt am Main, Germany.
Emmanuel DonnadieuInstitut Cochin, INSERM U1016, CNRS UMR 8104, Université Paris Cité, 75006 Paris, France.ORCID 0000-0002-4985-7254
Sylvia HartmannDr. Senckenberg Institute of Pathology, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0000-0003-3424-1091
Goethe University Frankfurt · DECentre National de la Recherche Scientifique · FRHelios Universitätsklinikum Wuppertal · DE

Funding

Deutsche Forschungsgemeinschaft HA6145/6-1 and HA6145/7-1
6 · The paper itself

Abstract

Nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL), is characterized by constitutional symptoms, advanced-stage disease, and generalized lymphadenopathy. A genetic hallmark of this lymphoma is the frequent occurrence of the

Indexed as

angioimmunoblastic T-cell lymphomalive cell imagingmovementRHOA mutation G17V

Identifiers

PMID37370838
PMCPMC10296629
OpenAlexW4381166167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.